Fish oil has spent years enjoying the nutritional equivalent of celebrity status. It has been promoted for the heart, brain, joints, inflammation, and, naturally, dry eyes. The theory sounded reasonable: omega-3 fatty acids have anti-inflammatory properties, and healthier oils in the tear film might slow evaporation. That was enough to put bottles of fish oil next to artificial tears in plenty of medicine cabinets.
Then researchers did something inconvenient for a popular health claim: they tested it in large, carefully controlled clinical trials.
The headline result was surprisingly unexciting. For typical patients with moderate-to-severe dry eye disease, high-dose fish-derived omega-3 supplements did not improve symptoms or objective eye findings significantly more than placebo. A later study examining whether omega-3 supplements could prevent dry eye also found no meaningful benefit, while newer randomized research involving meibomian gland dysfunction has added another negative result. In other words, fish oil is not the dry-eye superhero many people hoped it would be.
That does not mean omega-3 fatty acids are nutritionally useless, nor does it prove that no individual could ever notice improvement. It means something more specific and clinically important: the strongest evidence does not support routinely taking fish oil supplements specifically to treat or prevent dry eye disease.
Evidence basis: NEI-funded DREAM trial, JAMA Ophthalmology VITAL-Dry Eye trial, and subsequent randomized omega-3 research.
Why Fish Oil Seemed Like a Great Dry Eye Treatment
Before discussing why fish oil disappoints in clinical trials, it helps to understand why doctors and patients were interested in it in the first place.
Omega-3 fatty acids can influence inflammation
Fish oil typically supplies the long-chain omega-3 fatty acids EPA, or eicosapentaenoic acid, and DHA, or docosahexaenoic acid. These fats participate in biological pathways involved in inflammation and cell membrane function.
Because inflammation is an important component of many cases of dry eye disease, researchers reasonably wondered whether increasing EPA and DHA intake could calm inflammation on the ocular surface.
The eyelids need healthy oil
Your tears are not simply salty water. The tear film includes watery, oily, and mucin-related components that work together to keep the surface of the eye smooth and comfortable.
Tiny meibomian glands along the eyelids produce oils that help prevent tears from evaporating too quickly. When these glands become obstructed or dysfunctional, the tear film can disappear faster than a free doughnut in the office kitchen.
Because omega-3 intake can alter fatty-acid composition in the body, investigators theorized that supplementation might improve meibomian gland secretions and produce a more stable tear film.
It was a sensible hypothesis. A sensible hypothesis, unfortunately, is not the same thing as an effective treatment.
The DREAM Study Changed the Conversation
The most influential evidence came from the Dry Eye Assessment and Management study, better known as DREAM. Funded by the National Eye Institute, the multicenter randomized clinical trial enrolled 535 people with a history of moderate-to-severe dry eye symptoms.
Participants were treated at 27 clinical centers across the United States. Researchers randomly assigned 349 participants to receive fish-derived omega-3 supplements containing a total of 3,000 milligrams per day of EPA and DHA. The remaining 186 participants received an olive-oil placebo.
The omega-3 dose was substantial: 2,000 milligrams of EPA plus 1,000 milligrams of DHA every day. This was not a situation in which researchers gave participants one lonely little capsule and wondered why nothing happened.
Both groups improved
After one year, dry eye symptoms improved considerably in both groups.
On the Ocular Surface Disease Index, or OSDI, the omega-3 group improved by an average of about 13.9 points. The placebo group improved by approximately 12.5 points. The difference was not statistically significant.
About 61% of participants taking omega-3 supplements achieved at least a 10-point improvement in symptoms, compared with roughly 54% in the placebo group. Again, that difference was not statistically significant.
Objective measurements of dry eye did not reveal a convincing omega-3 advantage either. Tests evaluating tear production, tear-film quality, and damage to the cornea and conjunctiva showed no significant superiority for fish oil.
The practical conclusion was straightforward: high-dose omega-3 supplementation was no better than placebo as an additional treatment for typical patients with moderate-to-severe dry eye.
DREAM trial details and outcomes.
Why Did People Taking Placebo Feel Better?
This is one of the most interesting lessons from the DREAM trial. More than half of participants in the placebo group experienced a substantial improvement in symptoms.
That does not mean dry eye is imaginary. Far from it. Dry eye is a genuine ocular-surface disorder that can cause burning, stinging, grittiness, fluctuating vision, light sensitivity, excessive watering, and significant reductions in quality of life.
Instead, dry eye symptoms naturally fluctuate. Weather changes. Screen time changes. Medication use changes. People become more consistent with artificial tears or eyelid care after enrolling in a study. Simply receiving regular medical attention can improve treatment habits.
The placebo response also demonstrates why personal testimonials are unreliable evidence. Someone may take fish oil in January, improve in March, and logically conclude that the supplement worked. But without an appropriate comparison group, nobody knows whether the same improvement would have happened anyway.
Fish Oil Does Not Appear to Prevent Dry Eye Either
Perhaps omega-3 supplements are ineffective once dry eye becomes established but can prevent it from developing. Researchers have tested that possibility too.
A large randomized study associated with the nationwide VITAL trial evaluated 23,523 U.S. adults who did not have diagnosed dry eye at enrollment and were not experiencing severe dry eye symptoms.
Participants assigned to omega-3 supplementation received 1 gram of marine omega-3 fatty acids daily. After a median follow-up of approximately 5.3 years, supplementation did not significantly reduce new diagnoses of dry eye or the development of severe symptoms.
So the evidence offers another reality check: routine marine omega-3 supplementation does not appear to be an effective dry eye prevention strategy either.
VITAL-Dry Eye randomized clinical trial.
What About Meibomian Gland Dysfunction?
This question matters because meibomian gland dysfunction, or MGD, is one of the most common contributors to evaporative dry eye.
A 2024 randomized clinical trial specifically tested a re-esterified triglyceride form of omega-3 in 132 patients with dry eye associated with MGD. Participants received either omega-3 fatty acids or grape-seed oil for 12 weeks.
Symptoms improved in both groups, but omega-3 supplementation was not significantly superior to the comparison treatment at six or 12 weeks.
That does not settle every possible question about omega-3 formulations, doses, dietary patterns, or carefully selected patient subgroups. It does, however, make the blanket statement “fish oil fixes meibomian gland dry eye” difficult to defend.
2024 JAMA Ophthalmology randomized trial.
Why You May Still Hear Conflicting Advice
Search online for “fish oil for dry eyes” and you will quickly discover that medicine occasionally resembles a family group chat: several confident opinions appear at once.
Some older and smaller studies reported improvements with omega-3 supplementation. Observational research has also identified associations between dietary fatty-acid intake and eye health. Various medical resources still mention omega-3s as a possible complementary approach.
However, smaller studies can be affected by differences in supplement formulation, dose, participant selection, duration, control oils, other treatments, and outcome measurements. When a larger, independently funded, multicenter randomized trial produces a negative result, that evidence deserves considerable weight.
Harvard Health has similarly noted that although some earlier research suggested benefits, major randomized clinical trials have failed to demonstrate clear value for fish oil in dry eye prevention or treatment.
Summary of clinical interpretation.
Fish Is Still Food, and Food Is Not the Same as a Dry Eye Treatment
One mistake is jumping from “fish oil supplements do not reliably treat dry eye” to “omega-3 fatty acids are bad for you.” Those are completely different claims.
Fatty fish such as salmon, sardines, trout, herring, and mackerel can be part of a nutritious eating pattern. DHA is also an important structural component of tissues including the retina.
Eating fish as part of a balanced diet brings protein and multiple nutrients along for the ride. Taking several concentrated oil capsules specifically to make your eyes feel better is a different intervention with a different evidence base.
So there is no need to dramatically break up with salmon. It has done nothing wrong.
Fish Oil Supplements Are Not Completely Risk-Free
Omega-3 supplements are generally well tolerated, but “available without a prescription” does not mean “incapable of causing problems.”
Common adverse effects include an unpleasant taste, fishy breath, heartburn, nausea, stomach discomfort, and diarrhea. Supplements can also interact with medications and may be particularly relevant for people taking medicines that affect blood clotting.
Dietary supplements are regulated differently from prescription medications, so product quality and composition also deserve attention.
If you already take fish oil for another medical reason, do not stop a prescribed product based solely on a dry-eye article. Prescription omega-3 products have legitimate uses, including treatment of certain lipid disorders. Discuss medication changes with your healthcare professional.
Supplement safety and regulation information.
What Actually Helps Dry Eyes?
The best dry eye treatment depends on why your eyes are dry. Dry eye disease is not a single problem with a single solution.
Artificial tears
Over-the-counter lubricating drops remain a common first-line option for mild symptoms. People who use drops frequently may be advised to consider preservative-free formulations.
Warm compresses and eyelid hygiene
When meibomian gland dysfunction contributes to evaporative dry eye, warm compresses and proper eyelid hygiene may help loosen thickened gland secretions and improve oil flow.
Screen and environmental changes
Long periods of concentrated computer or smartphone use can reduce blinking. Taking visual breaks, deliberately blinking, positioning screens properly, avoiding direct airflow, and using a humidifier in dry environments may reduce symptoms.
Prescription medications
Moderate or persistent dry eye may require prescription anti-inflammatory treatments such as cyclosporine or lifitegrast. Short courses of corticosteroid eye drops are sometimes used under professional supervision.
Tear-conservation treatments
Punctal plugs can reduce drainage of tears from the eye in appropriately selected patients. Moisture-retaining eyewear and nighttime ointments may also help particular types of dry eye.
MGD-focused procedures
Some patients with significant meibomian gland dysfunction undergo professional gland expression, thermal treatments, or other office-based procedures. Their usefulness depends on the individual diagnosis and should be discussed with an eye-care professional.
The Diagnosis Matters More Than the Supplement Aisle
If dry eye symptoms persist, determining the underlying cause is often more valuable than trying a longer list of supplements.
Someone with reduced tear production may need a different strategy from someone whose tears evaporate rapidly because of blocked meibomian glands. Allergies, blepharitis, contact lenses, autoimmune disease, medications, eyelid abnormalities, hormonal changes, previous eye surgery, and environmental exposure can all play roles.
Dry eye can even cause excessive tearing. When the ocular surface becomes irritated, reflex tearing may kick in. The result is the wonderfully confusing experience of having watery eyes because your eyes are dry.
A comprehensive eye examination can identify clues that a supplement bottle cannot.
Does “Fish Oil Doesn’t Help Dry Eyes” Mean Nobody Benefits?
No scientific trial can prove that not a single person on Earth will ever feel better while taking fish oil.
Clinical research asks a more useful question: compared with an appropriate control, do people taking the treatment improve enough and consistently enough to justify recommending it?
For omega-3 supplements and common dry eye disease, the strongest large randomized studies have not demonstrated that level of benefit.
This distinction prevents two opposite mistakes. We should not claim that fish oil is a proven dry eye treatment simply because some people report improvement. We also should not claim omega-3s have zero biological effects simply because a clinical trial produced a negative dry-eye result.
The sensible position is wonderfully boring: use the best available evidence, treat the actual cause of dry eye, and save miracle language for comic books.
Practical Experiences: What People Often Discover When Fish Oil Fails to Fix Dry Eyes
The real-world dry eye experience often starts with a deceptively simple complaint: “My eyes feel dry.” A person who spends eight hours working at a computer may notice burning in the afternoon and blurry vision that briefly clears after blinking. They search online, find several recommendations for omega-3 supplements, buy a large bottle, and begin taking capsules every morning.
A month later, things seem slightly better. Naturally, the capsules receive the credit.
But February has also become less dry than January. The person installed a humidifier, started taking lunch away from the computer, and unconsciously became more diligent about using lubricating drops. That is exactly why individual experience cannot determine which intervention deserves the trophy.
Another common scenario involves meibomian gland dysfunction. Imagine someone whose eyes burn every evening and feel gritty after driving. Fish oil sounds logical because eyelid glands produce the oily layer of tears. Yet an examination reveals thickened gland secretions and inflamed eyelid margins.
In that situation, improving eyelid care and treating the gland dysfunction directly may matter far more than swallowing additional omega-3 capsules. The patient may begin warm compresses, eyelid cleansing, appropriately selected lubricating drops, and other treatment recommended by an eye doctor. Symptoms finally improvenot because somebody found a more expensive fish oil, but because the treatment matched the problem.
Contact lens wearers provide another useful example. A person may comfortably wear lenses in the morning but feel increasing dryness after six or seven hours. Adding fish oil does not change lens fit, blinking behavior, tear evaporation, or hours spent staring at a monitor. Adjusting lens type or wearing schedule, taking screen breaks, and evaluating the ocular surface may produce a much more noticeable difference.
Then there is the person who says, “But fish oil really did help me.” That experience should not be dismissed. Symptoms are personal, and genuine improvement matters. What cannot be established from one experience is why the improvement occurred.
Dry eye naturally has good days and bad days. Symptoms can change with sleep, hydration, allergies, medications, air conditioning, heating, outdoor wind, screen time, contact lens use, and countless other variables. A treatment started during a particularly bad period may appear spectacular simply because symptoms were likely to move back toward their usual level anyway.
The DREAM study beautifully demonstrated this problem. Both groups improved substantially despite only one group receiving high-dose fish-derived omega-3s. If every participant had been observed individually without a placebo comparison, many people in both groups could reasonably have believed their assigned capsules were responsible for their improvement.
The most useful experience, therefore, is not “I tried fish oil and it worked” or “I tried it and it failed.” It is learning to approach persistent dry eye systematically. Identify triggers. Track when symptoms occur. Review medications. Examine the eyelids and tear film. Determine whether the problem is predominantly evaporative, aqueous-deficient, inflammatory, or mixed. Then choose treatments that target those findings.
That approach is less exciting than discovering a miracle capsule. It is also considerably more useful.
Conclusion: Treat the Dry Eye, Not the Marketing Claim
Fish oil became popular for dry eye because the biological explanation was appealing and early evidence offered reasons for optimism. Better clinical trials have changed the picture.
The NEI-funded DREAM study found that 3 grams per day of fish-derived EPA and DHA did not outperform placebo in people with moderate-to-severe dry eye. Long-term omega-3 supplementation also failed to prevent dry eye in a large randomized U.S. study, while additional randomized research has failed to demonstrate a clear advantage in patients with meibomian gland dysfunction.
That makes routine fish oil supplementation a poor choice as a stand-alone solution for dry eyes. A better strategy is to determine what is disrupting the tear film and use targeted treatments such as lubricating drops, warm compresses, eyelid care, environmental adjustments, prescription therapy, or other interventions when appropriate.
Omega-3-rich foods can still belong in a healthy diet, and some people may take omega-3 products for reasons unrelated to dry eye. The important lesson is simply that nutritional value and proven disease treatment are not interchangeable concepts.
Note: This article provides general educational information and is not a substitute for diagnosis or treatment by an ophthalmologist, optometrist, or other qualified healthcare professional. Persistent dry eye, significant eye pain, marked redness, light sensitivity, injury, or sudden changes in vision should be evaluated promptly.
